Blixt et al. (2018).  found that EPO can reduce traumatic cell edema by protecting the structure and functional characteristics of the blood-brain barrier after experimental craniocerebral trauma. In addition, Moransard and colleagues discovered that EPO alleviates the severity of experimental autoimmune encephalomyelitis by improving the survival of spinal cord neurons (Moransard et al., 2017). The gene discussed is EPO; the disease is experimental autoimmune encephalomyelitis.